Minimal Important Difference for Rescue Opioid Consumption in Adults With Acute Pain: A Scoping Review
Authors:
- Atena SaitoASAtena Saito
- Jens LaigaardJLJens Laigaard
- Pernille Bjersand SundePSPernille Bjersand Sunde
- Caroline FolkersenCFCaroline Folkersen
- Ida Houtved RasmussenIRIda Houtved Rasmussen
- Selma Pedersen KjartansdóttirSKSelma Pedersen Kjartansdóttir
- Ole MathiesenOMOle Mathiesen
- Anders KarlsenAKAnders Karlsen
- 6 November 2025
- journal article
- review article
- Published by Wiley in European journal of pain
- Vol. 29 (10) , e70151
Abstract
Background: The minimal important difference (MID) is established for pain intensity scores in acute pain management, but not for rescue opioid consumption. This scoping review aimed to estimate the MID in rescue opioid consumption for acute pain among adult patients in the postoperative and emergency settings. Methods: We searched MEDLINE, Embase, CENTRAL, clinicaltrials.gov and clinicaltrialsregister.eu for studies published in English from inception to May 2024. We included studies investigating the MID of rescue opioid consumption in adults with acute pain in the postoperative and emergency settings. Because limited studies explicitly investigated the MID, we also included studies assessing the dose–response relationship between opioid consumption and relevant anchors (e.g., pain intensity scores). The primary outcome was MID for 0–24 h rescue opioid consumption; secondary outcomes included longer postoperative periods. Results: We screened 11,748 citations and included 14 studies (8190 patients). Three studies explicitly evaluated MID for rescue opioid consumption. In the remaining 11 studies, we estimated the MID using a 10‐point difference (0–100 scale) in pain intensity score as an anchor. The anchor‐based estimates ranged from 2 to 5 mg IV morphine equivalents, varying by population, method and context. Conclusions: Based on the currently available evidence, we propose a provisional MID of 5 mg IV morphine equivalent in rescue opioid consumption for acute pain. This is lower than the value used in most sample size calculations. Significance Statement: These results can guide sample size calculations and support patient‐centered approaches in acute pain settings. Trial Registration: PROSPERO identifier: CRD42024547409Keywords
This publication has 22 references indexed in Scilit:
- Minimal clinically important differences in randomised clinical trials on pain management after total hip and knee arthroplasty: a systematic reviewBritish Journal of Anaesthesia, 2021
- Minimal important difference estimates for patient-reported outcomes: A systematic surveyJournal of Clinical Epidemiology, 2021
- Side effects from opioids used for acute pain after emergency department dischargeThe American Journal of Emergency Medicine, 2020
- Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studiesJournal of Clinical Epidemiology, 2018
- How Much Pain Is Significant? Defining the Minimal Clinically Important Difference for the Visual Analog Scale for Pain After Total Joint ArthroplastyThe Journal of Arthroplasty, 2018
- Intravenous morphine titration as a rapid and efficient analgesia for adult patients with femoral shaft fractures after injuryThe American Journal of Emergency Medicine, 2016
- Dose-response relationship after single oral dose administrations of morphine and oxycodone using laser-evoked potentials on UVB- and capsaicin-irritated skin in healthy male subjectsPain, 2012
- Single-Dose Intravenous Tramadol for Acute Migraine Pain in Adults: A Single-Blind, Prospective, Randomized, Placebo-Controlled Clinical TrialClinical Therapeutics, 2007
- Intravenous Morphine at 0.1 mg/kg Is Not Effective for Controlling Severe Acute Pain In the Majority of PatientsAnnals of Emergency Medicine, 2005
- Dose-response relationship between opioid use and adverse effects after ambulatory surgeryJournal of Pain and Symptom Management, 2004